FibroScan-based assessment tool: best predictor of bad liver outcomes if NAFLD/MASLD
A recent article found that the Agile assessment using vibration-controlled transient elastography (eg, FibroScan) was highly predictive of liver-related events in patients with metabolic dysfunction-associated steatotic liver disease (MASLD, otherwise known as MAFLD, as well as NAFLD of yore), see NAFLD fibroscan JAMA2024 in dropbox, or doi:10.1001/jama.2024.1447) Details : -- 16,603 patients from 16 tertiary referral centers in the US, Europe, and Asia, in a study from February 2004 to January 2023 with data collected prospectively -- eligible patients were adults aged at least 18yo with hepatic steatosis (steatosis in at least 5% of hepatocytes found on histologic exam), or imaging studies (ultrasound, CT, MRI, or vibration-controlled transient elastography (VCTE) finding controlled attenuation parameter of at least 248 dB/m ) -- patients were excluded if they had other liver diseases such as viral hepatitis, HIV, excessive alco...